| Systematic (IUPAC) name | |
|---|---|
| N-allyl-N-[2-(5-methoxy -1H-indol-3-yl)ethyl] prop-2-en-1-amine |
|
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 928822-98-4 |
| ATC code | ? |
| PubChem | CID 50878551 |
| ChemSpider | 21106245 |
| Chemical data | |
| Formula | C17H22N2O |
| Mol. mass | 270.375 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
5-MeO-DALT or N,N-diallyl-5-methoxytryptamine is a psychedelic tryptamine first synthesized by Alexander Shulgin.
|
Contents
|
The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is chemically related to the compounds 5-MeO-DPT and DALT.
The first material regarding the synthesis and effects of 5-MeO-DALT was sent from Alexander Shulgin to a researcher named Murple in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet research chemical vendors. In August 2004 the synthesis and effects of 5-MeO-DALT were published by Erowid. [1]
Doses ranging from 12-20 mg were tested by Alexander Shulgin's research group. [2]
There are numerous anecdotal reports of users consuming dosages far in excess those tested by Alexander Shulgin, there is no published literature on the toxicity of 5-MeO-DALT. By far, the most dangerous effect seems to be retrograde amnesia from consuming excess amounts of this material.
5-MeO-DALT is unscheduled in the United States. It is also legal in the UK because the allyl group is not an alkyl group, which the law requires for a tryptamine to be illegal.
|
|||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)